Community Oncology Connections™: Monotherapies vs Combinations – Navigating Oral SERDs and Targeted Combination Strategies in HR+/HER2- Metastatic Breast Cancer
Wednesday, September 2, 2026
5:15 PM - 6:15 PM PT
This program brings together expert faculty to discuss the latest advances and enable the integration of oral SERDs and emerging combination strategies into HR+/HER2- metastatic breast cancer care.
Community Oncology Connections™: Bridging Academic and Community Expertise in Evidence-Based Care for Desmoid Tumors
Wednesday, October 28, 2026
5:15 PM - 6:15 PM PT
This program will be delivered as a series of 8 live, CME-certified virtual meetings in collaboration with ACCC-affiliated Oncology State Societies, supported by an enduring online activity. Using an interactive, case-based format tailored to community oncology practice, these virtual meetings include expert presentations on recent data from clinical trials of desmoid tumors, followed by case presentations, discussions and learner question and answers.
Community Oncology Connections™: How Can We Optimize the Use of Oral SERDs in the Community Oncology Setting? Best Practices for HR+/HER2- Breast Cancer
Wednesday, November 4, 2026
5:15 PM - 6:15 PM PT
This online, CME-certified Community Oncology Connections – How Can We Optimize the Use of Oral SERDs in the Community Oncology Setting? Best Practices for HR+/HER2- Breast Cancer, will bring together expert faculty to review the key recent findings and discuss their potential implications for community oncologists.